These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30378481)

  • 1. The Mycobacterial HBHA Protein: A Promising Biomarker for Tuberculosis.
    De Maio F; Squeglia F; Goletti D; Delogu G
    Curr Med Chem; 2019; 26(11):2051-2060. PubMed ID: 30378481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
    Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
    Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
    Delogu G; Vanini V; Cuzzi G; Chiacchio T; De Maio F; Battah B; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.
    Place S; Verscheure V; de San N; Hougardy JM; Schepers K; Dirix V; Dediste A; Michel O; Drowart A; Allard SD; Doherty TM; Lecher S; Locht C; Mascart F
    Am J Respir Crit Care Med; 2010 Sep; 182(6):848-54. PubMed ID: 20508213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
    Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
    Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis.
    Parra M; Pickett T; Delogu G; Dheenadhayalan V; Debrie AS; Locht C; Brennan MJ
    Infect Immun; 2004 Dec; 72(12):6799-805. PubMed ID: 15557600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.
    Delogu G; Chiacchio T; Vanini V; Butera O; Cuzzi G; Bua A; Molicotti P; Zanetti S; Lauria FN; Grisetti S; Magnavita N; Fadda G; Girardi E; Goletti D
    PLoS One; 2011 Mar; 6(3):e18315. PubMed ID: 21479248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
    Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
    Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportions of interferon-γ-producing ascites lymphocytes in response to mycobacterial antigens: A help for early diagnosis of peritoneal tuberculosis in a low TB incidence country.
    Henrard S; Corbière V; Schandené L; Ducarme M; Van Praet A; Petit E; Singh M; Locht C; Dirix V; Mascart F
    PLoS One; 2019; 14(4):e0214333. PubMed ID: 30946755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis.
    Locht C; Hougardy JM; Rouanet C; Place S; Mascart F
    Tuberculosis (Edinb); 2006; 86(3-4):303-9. PubMed ID: 16510310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis HBHA protein reacts strongly with the serum immunoglobulin M of tuberculosis patients.
    Shin AR; Lee KS; Lee JS; Kim SY; Song CH; Jung SB; Yang CS; Jo EK; Park JK; Paik TH; Kim HJ
    Clin Vaccine Immunol; 2006 Aug; 13(8):869-75. PubMed ID: 16893986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Purification of the heparin-binding haemagglutinin adhesin of Mycobacterium tuberculosis and its application in diagnosis of tuberculosis].
    Zhang XX; Sun ZG; Li Y; Zhang JY; Duanmu HJ; Li CY
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):448-52. PubMed ID: 19031806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.
    Corbière V; Pottier G; Bonkain F; Schepers K; Verscheure V; Lecher S; Doherty TM; Locht C; Mascart F
    PLoS One; 2012; 7(8):e43285. PubMed ID: 22912846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
    Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
    Front Immunol; 2018; 9():308. PubMed ID: 29535713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design.
    Karbalaei Zadeh Babaki M; Soleimanpour S; Rezaee SA
    Microb Pathog; 2017 Nov; 112():20-29. PubMed ID: 28942172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.